books search
books
articles search
articles
Donate
Log In
Log In
to access more features
personal recommendations
Telegram Bot
download history
send to Email or Kindle
manage booklists
save to favorites
Personal
Book Requests
Explore
Journals
Contribution
Donate
Litera Library
Donate paper books
Add paper books
Open LITERA Point
Volume 30; Issue 3
Main
Investigational New Drugs
Volume 30; Issue 3
Investigational New Drugs
Volume 30; Issue 3
1
Further developments for improving response and tolerance to irradiation for advanced renal cancer: concurrent (mTOR) inhibitor RAD001 and helical tomotherapy
Youlia M. Kirova, Vincent Servois, Cyrus Chargari, Malika Amessis, Marc Zerbib, Philippe Beuzeboc
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 321 KB
Your tags:
english, 2012
2
Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer
Dirk Strumberg, Beate Schultheis, M. E. Scheulen, R. A. Hilger, J. Krauss, N. Marschner, F. Lordick, F. Bach, D. Reuter, L. Edler, K. Mross
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 144 KB
Your tags:
english, 2012
3
Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in rats
Pius Maliakal, Maen Abdelrahim, Umesh T. Sankpal, Cima Maliakal, Cheryl H. Baker, Stephen Safe, Luis J. Herrera, Ala Abudayyeh, Sumanth Kaja, Riyaz Basha
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 403 KB
Your tags:
english, 2012
4
Caspase-independent apoptosis induction of quorum-sensing autoinducer analogs against chronic myeloid leukemia K562
Masaharu Hazawa, Michiko Kudo, Toshihiro Iwata, Kazuki Saito, Kenji Takahashi, Jun Igarashi, Hiroaki Suga, Ikuo Kashiwakura
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 392 KB
Your tags:
english, 2012
5
Everolimus-related organizing pneumonia: a report establishing causality
Justine Frija, Dominique Joly, Bertrand Knebelmann, Daniel Dusser, Pierre-Régis Burgel
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 134 KB
Your tags:
english, 2012
6
Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells
David Davidson, Yannick Coulombe, Veronica L. Martinez-Marignac, Lilian Amrein, Jeremy Grenier, Keira Hodkinson, Jean-Yves Masson, Raquel Aloyz, Lawrence Panasci
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 278 KB
Your tags:
english, 2012
7
TRAIL shows potential cardioprotective activity
Barbara Toffoli, Stella Bernardi, Riccardo Candido, Serena Zacchigna, Bruno Fabris, Paola Secchiero
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 281 KB
Your tags:
english, 2012
8
Antimetastatic activity and low systemic toxicity of tetradecyl gallate in a preclinical melanoma mouse model
Claudriana Locatelli, Deborah Regina Carvalho, Alessandra Mascarello, Clarissa Amorin Silva de Cordova, Rosendo Augusto Yunes, Ricardo Jose Nunes, Celso Pilati, Tânia Beatriz Creczynski-Pasa
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 1.00 MB
Your tags:
english, 2012
9
Phase I study ofcontinuousMKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation design
Amye Tevaarwerk, George Wilding, Jens Eickhoff, Rick Chappell, Carolyn Sidor, Jamie Arnott, Howard Bailey, William Schelman, Glenn Liu
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 128 KB
Your tags:
english, 2012
10
Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma
Masashi Niwakawa, Katsuyoshi Hashine, Raizo Yamaguchi, Hirofumi Fujii, Yasuo Hamamoto, Koichi Fukino, Takahiko Tanigawa, Yoshiteru Sumiyoshi
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 359 KB
Your tags:
english, 2012
11
A randomized phase II study of recombinant human endostatin plus gemcitabine/cisplatin compared with gemcitabine/cisplatin alone as first-line therapy in advanced non-small-cell lung cancer
Xin Zhao, Kai Mei, Xiaohong Cai, Jing Chen, Jingrui Yu, Chengya Zhou, Qiu Li
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 136 KB
Your tags:
english, 2012
12
Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study
Soohyeon Lee, Sang Hyun Yoon, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Hye Jin Choi
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 178 KB
Your tags:
english, 2012
13
Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients
Yutaka Fujiwara, Naomi Kiyota, Naoko Chayahara, Akiyuki Suzuki, Yoshiko Umeyama, Toru Mukohara, Hironobu Minami
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 312 KB
Your tags:
english, 2012
14
Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma
Steven J. O’Day, Anna C. Pavlick, Mark R. Albertini, Omid Hamid, Heidi Schalch, Zhihui Lang, Jie Ling, Marielena Mata, Manjula Reddy, Brenda Foster
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 232 KB
Your tags:
english, 2012
15
Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model
Timothy P. Burkholder, Joshua R. Clayton, Mark E. Rempala, James R. Henry, John M. Knobeloch, David Mendel, Johnathan A. McLean, Yan Hao, David A. Barda, Eileen L. Considine, Mark T. Uhlik, Yuefeng Ch
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 1007 KB
Your tags:
english, 2012
16
In vitro antitumor mechanism of a novel cyclin-dependent kinase inhibitor CDKI-83
Xiangrui Liu, Frankie Lam, Shenhua Shi, Peter M. Fischer, Shudong Wang
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 538 KB
Your tags:
english, 2012
17
Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel
Michael Millward, Paul Mainwaring, Alain Mita, Kristine Federico, G. K. Lloyd, Natasha Reddinger, Steffan Nawrocki, Monica Mita, Matthew A. Spear
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 274 KB
Your tags:
english, 2012
18
Inhibition of TGF-β signaling, vasculogenic mimicry and proinflammatory gene expression by isoxanthohumol
Annegret Serwe, Kristina Rudolph, Timm Anke, Gerhard Erkel
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 881 KB
Your tags:
english, 2012
19
Targeting angiogenesis from multiple pathways simultaneously: BIBF 1120, an investigational novel triple angiokinase inhibitor
Edgardo S. Santos, Jorge E. Gomez, Luis E. Raez
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 272 KB
Your tags:
english, 2012
20
Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice
Grace-Ifeyinwa Onimoe, Aiguo Liu, Li Lin, Chang-Ching Wei, Eric B. Schwartz, Deepak Bhasin, Chenglong Li, James R. Fuchs, Pui-kai Li, Peter Houghton, Amanda Termuhlen, Thomas Gross, Jiayuh Lin
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 709 KB
Your tags:
english, 2012
21
Hepatic arterial infusion (HAI) with PEGylated liposomes containing 5-FU improves tumor control of liver metastases in a rat model
Uwe Pohlen, Heinz J. Buhr, Gerd Berger, Jörg-Peter Ritz, Christoph Holmer
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 652 KB
Your tags:
english, 2012
22
DNA interstrand cross-linking andin vivoantitumor activity of the extended pyrrolo[2,1-c][1,4]benzodiazepine dimer SG2057
John A. Hartley, Anzu Hamaguchi, Marie Suggitt, Stephen J. Gregson, David E. Thurston, Philip W. Howard
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 357 KB
Your tags:
english, 2012
23
Progression-free survival and time to progression as surrogate markers of overall survival in patients with advanced gastric cancer: analysis of 36 randomized trials
Kohei Shitara, Junko Ikeda, Tomoya Yokota, Daisuke Takahari, Takashi Ura, Kei Muro, Keitaro Matsuo
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 288 KB
Your tags:
english, 2012
24
Cell cycle arrest through inhibition of tubulin polymerization by withaphysalin F, a bioactive compound isolated fromAcnistus arborescens
Danilo D. Rocha, Aruna Balgi, Ana Isabel V. Maia, Otilia D. Pessoa, Edilberto R. Silveira, Letícia V. Costa-Lotufo, Michel Roberge, Claudia Pessoa
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 600 KB
Your tags:
english, 2012
25
A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium
Helen J. Mackay, Heather J. Au, Elaine McWhirter, Thierry Alcindor, Andrea Jarvi, Katrina MacAlpine, Lisa Wang, John J. Wright, Amit M. Oza
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 116 KB
Your tags:
english, 2012
26
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research
Do-Youn Oh, Keun Wook Lee, Kyung-Hee Lee, Chang-Hak Sohn, Young Suk Park, Dae Young Zang, Hun-Mo Ryoo, Hong-Suk Song, Jin-Soo Kim, Hye-Jin Kang, Bong-Seog Kim, Yung-Jue Bang
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 224 KB
Your tags:
english, 2012
27
A phase I trial of MK-0731, a Kinesin Spindle Protein (KSP) inhibitor, in patients with solid tumors
Kyle Holen, Robert DiPaola, Glenn Liu, Antoinette R. Tan, George Wilding, Karl Hsu, Nancy Agrawal, Cong Chen, Lingling Xue, Elizabeth Rosenberg, Mark Stein
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 242 KB
Your tags:
english, 2012
28
Second-generation taxanes effectively suppress subcutaneous rat lymphoma: role of disposition, transport, metabolism, in vitro potency and expression of angiogenesis genes
Berta Otová, Iwao Ojima, Radka Václavíková, Jiří Hrdý, Marie Ehrlichová, Pavel Souček, Jana Vobořilová, Vlasta Němcová, Ilaria Zanardi, Stanislav Horský, Jan Kovář, Ivan Gut
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 602 KB
Your tags:
english, 2012
29
Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2
Alicia A. Goyeneche, Erin E. Seidel, Carlos M. Telleria
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 798 KB
Your tags:
english, 2012
30
A phase I trial of vandetanib combined with capecitabine, oxaliplatin and bevacizumab for the first-line treatment of metastatic colorectal cancer
Elwyn C. Cabebe, George A. Fisher, Branimir I. Sikic
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 112 KB
Your tags:
english, 2012
31
In vivo toxicity study ofN-1-sulfonylcytosine derivatives and their mechanisms of action in cervical carcinoma cell line
Jelena Kašnar-Šamprec, Ivana Ratkaj, Katarina Mišković, Marina Pavlak, Mirela Baus-Lončar, Sandra Kraljević Pavelić, Ljubica Glavaš-Obrovac, Biserka Žinić
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 375 KB
Your tags:
english, 2012
32
A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer
A. B. El-Khoueiry, R. K. Ramanathan, D. Y. Yang, W. Zhang, S. Shibata, J. J. Wright, D. Gandara, H. J. Lenz
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 244 KB
Your tags:
english, 2012
33
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia
H. M. Kantarjian, S. Padmanabhan, W. Stock, M. S. Tallman, G. A. Curt, J. Li, A. Osmukhina, K. Wu, D. Huszar, G. Borthukar, S. Faderl, G. Garcia-Manero, T. Kadia, K. Sankhala, O. Odenike, et al
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 188 KB
Your tags:
english, 2012
34
Aminopyrimidoisoquinolinequinone (APIQ) redox cycling is potentiated by ascorbate and induces oxidative stress leading to necrotic-like cancer cell death
David R. Vásquez, Julien Verrax, Jaime A. Valderrama, Pedro Buc Calderon
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 502 KB
Your tags:
english, 2012
35
A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials
Axel Le Cesne, Alejandro Yovine, Jean-Yves Blay, Suzette Delaloge, Robert G. Maki, Jean-Louis Misset, Pilar Frontelo, Antonio Nieto, Juhui James Jiao, George D. Demetri
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 269 KB
Your tags:
english, 2012
36
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group)
Beate Schultheis, Dirk Strumberg, Lothar Bergmann, Ullrich Graeven, Axel-Rainer Hanauske, Rainer Lipp, Jochen Schuette, K. Saito, Paul Scigalla, Max E. Scheulen
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 283 KB
Your tags:
english, 2012
37
A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumors
Akira Fukutomi, Kiyohiko Hatake, Kaoru Matsui, Sakura Sakajiri, Tomonori Hirashima, Hiromi Tanii, Ken Kobayashi, Nobuyuki Yamamoto
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 223 KB
Your tags:
english, 2012
38
A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifen
Dennis Ma, Phillip Tremblay, Kevinjeet Mahngar, Pardis Akbari-Asl, Jonathan Collins, Tomas Hudlicky, James McNulty, Siyaram Pandey
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 1.19 MB
Your tags:
english, 2012
39
Multifunctional 5-aminolevulinic acid prodrugs activating diverse cell-death pathways
Gili Berkovitch-Luria, Michal Weitman, Abraham Nudelman, Ada Rephaeli, Zvi Malik
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 2.83 MB
Your tags:
english, 2012
40
Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia
Simona Lapusan, Maria B. Vidriales, Xavier Thomas, Stephane de Botton, Anne Vekhoff, Ruoping Tang, Charles Dumontet, Rodica Morariu-Zamfir, John M. Lambert, Marie-Laure Ozoux, Philippe Poncelet, Jesus
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 482 KB
Your tags:
english, 2012
41
Reappraisal of treatment-induced renal dysfunction in patients receiving antiangiogenic agents in phase I trials
Antonin Levy, Laurence Albiges-Sauvin, Christophe Massard, Hassan Izzedine, Stéphane Edhery, Ratio Bahleda, Carlos Gomez-Roca, Cyrus Chargari, Isabelle Brocheriou-Spelle, Jean-Charles Soria
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 122 KB
Your tags:
english, 2012
42
A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer
Daniel J. Renouf, Patricia A. Tang, Pierre Major, Monika K. Krzyzanowska, Bindi Dhesy-Thind, John R. Goffin, David Hedley, Lisa Wang, L. Doyle, Malcolm J. Moore
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 115 KB
Your tags:
english, 2012
43
Safety and pharmacokinetic study ofnab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non–small cell lung cancer
Isamu Okamoto, Nobuyuki Yamamoto, Kaoru Kubota, Yuichiro Ohe, Naoyuki Nogami, Haruyasu Murakami, Hidetoshi Yamaya, Katsuhiro Ono, Kazuhiko Nakagawa
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 161 KB
Your tags:
english, 2012
44
The fate of camptothecin glycoconjugate: report of a clinical hold during a phase II study of BAY 56-3722 (formerly BAY 38-3441), in patients with recurrent or metastatic colorectal cancer resistant/refractory to irinotecan
Marije Slingerland, Hans Gelderblom
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 83 KB
Your tags:
english, 2012
45
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium
Manish R. Sharma, Kristen Wroblewski, Blase N. Polite, James A. Knost, James A. Wallace, Sanjiv Modi, Bethany G. Sleckman, David Taber, Everett E. Vokes, Walter M. Stadler, Hedy L. Kindler
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 162 KB
Your tags:
english, 2012
46
Erratum to: Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model
Timothy P. Burkholder, Joshua R. Clayton, Mark E. Rempala, James R. Henry, John M. Knobeloch, David Mendel, Johnathan A. McLean, Yan Hao, David A. Barda, Eileen L. Considine, Mark T. Uhlik, Yuefeng Ch
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 401 KB
Your tags:
english, 2012
47
A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy
György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella, Tudor Eliade Ciuleanu, G. Pover, N. C. Tebbutt
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 640 KB
Your tags:
english, 2012
48
Erratum to: A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy
György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella, Tudor Eliade Ciuleanu, G. Pover, N. C. Tebbutt
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 61 KB
Your tags:
english, 2012
49
A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia
Craig Reynolds, Nicholas Di Bella, Roger M. Lyons, William Hyman, Donald A. Richards, Gerald J. Robbins, Mark Vellek, Kristi A. Boehm, Feng Zhan, Lina Asmar
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 160 KB
Your tags:
english, 2012
50
Erratum to: Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma
Masashi Niwakawa, Katsuyoshi Hashine, Raizo Yamaguchi, Hirofumi Fujii, Yasuo Hamamoto, Koichi Fukino, Takahiko Tanigawa, Yoshiteru Sumiyoshi
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 65 KB
Your tags:
english, 2012
51
Erratum to: Reappraisal of treatment-induced renal dysfunction in patients receiving antiangiogenic agents in phase I trials
Antonin Levy, Laurence Albiges-Sauvin, Christophe Massard, Hassan Izzedine, Stéphane Ederhy, Ratio Bahleda, Carlos Gomez-Roca, Cyrus Chargari, Isabelle Brocheriou-Spelle, Jean-Charles Soria
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 57 KB
Your tags:
english, 2012
52
Erratum to: Nimbolide a limonoid fromAzadirachta indicainhibits proliferation and induces apoptosis of human choriocarcinoma (BeWo) cells
G. Harish Kumar, K. V. P. Chandra Mohan, A. Jagannadha Rao, S. Nagini
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 62 KB
Your tags:
english, 2012
53
A cytotoxic ribonuclease reduces the expression level of P-glycoprotein in multidrug-resistant cell lines
Jessica Castro, Marc Ribó, Teresa Puig, Ramon Colomer, Maria Vilanova, Antoni Benito
Journal:
Investigational New Drugs
Year:
2012
Language:
english
File:
PDF, 269 KB
Your tags:
english, 2012
1
Follow
this link
or find "@BotFather" bot on Telegram
2
Send /newbot command
3
Specify a name for your chatbot
4
Choose a username for the bot
5
Copy an entire last message from BotFather and paste it here
×
×